These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 184610)

  • 1. [The diagnostic importance of low-density lipoprotein (LP-X) for the diagnosis of cholestasis].
    Michel B; Ritter U
    Z Gastroenterol; 1976 Sep; 14(5):556-64. PubMed ID: 184610
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipoprotein-X in patients with cirrhosis: its relationship to cholestasis and hypercholesterolemia.
    Sörös P; Böttcher J; Maschek H; Selberg O; Müller MJ
    Hepatology; 1998 Nov; 28(5):1199-205. PubMed ID: 9794902
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic importance of lipoprotein-X (LP-X) in the diagnosis of cholestasis.
    Palynyczko Z; Milewski B
    Mater Med Pol; 1975; 7(4):327-33. PubMed ID: 175222
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Lipoprotein X in hepatobiliary diseases].
    Mordasini RC; Berthold S; Schlumpf E; Keller H; Riva G
    Schweiz Med Wochenschr; 1975 Jul; 105(27):863-72. PubMed ID: 2969
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipoprotein-X levels in extrahepatic versus intrahepatic cholestasis.
    Simon JB; Poon RW
    Gastroenterology; 1978 Aug; 75(2):177-80. PubMed ID: 208914
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Significance of serum lipoproteid-X (LP-X) determination for the diagnosis of cholestasis in chronic liver diseases.
    Milewski B; Palynyczko Z
    Pol Med Sci Hist Bull (1973); 1975; 15(5-6):551-5. PubMed ID: 1228704
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LP-X in cholestasis.
    Tanno H; Fay O; Palazzi J; Pedrana R; Yäger E; Roncoroni M
    Acta Hepatogastroenterol (Stuttg); 1975 Oct; 22(5):289-91. PubMed ID: 173123
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The serum lipoprotein X (LP-X) test in the diagnosis of cholestatic hepatopathies (preliminary note)].
    Colalongo G; Nubile G; Fiorentini GP; Tabacchi L; Beltrandi E
    Boll Soc Ital Biol Sper; 1974 Sep; 50(18):1440-5. PubMed ID: 4458730
    [No Abstract]   [Full Text] [Related]  

  • 9. [LP-X in newborns: increased incidence of positive tests without cholestasis (author's transl)].
    Witt I; Ober M
    J Clin Chem Clin Biochem; 1976 Apr; 14(4):197-202. PubMed ID: 5573
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Diagnostic value of the lipoprotein-X determination (author's transl)].
    Wepler R; Rommel K
    J Clin Chem Clin Biochem; 1978 Oct; 16(10):543-5. PubMed ID: 712333
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lipoprotein-X and diagnosis of cholestasis: comparison with other biochemical parameters and liver biopsy.
    Fellin R; Manzato E; Zotti S; Baggio G; Briani G; Rugge M
    Clin Chim Acta; 1978 Apr; 85(1):41-7. PubMed ID: 25728
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Abnormal lipoprotein (LP-X) in the first months of life with particular reference to obstructive jaundice (author's transl)].
    Lachmann D
    Wien Klin Wochenschr Suppl; 1977; 69():3-28. PubMed ID: 266315
    [TBL] [Abstract][Full Text] [Related]  

  • 13. On the occurrence of lipoprotein-x in non-hemolytic jaundice.
    Samsioe G; Lundborg H; Ivarsson S; Gustafson A
    Acta Chir Scand; 1976; 142(3):187-90. PubMed ID: 180734
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Frequency of lipoprotein-X (LP-X) in icteric patients. Comparison with some bioquimical data (author's transl)].
    Higashi T; Carvalho LC; Seki M; Onishi MH; Zeitune JM
    Arq Gastroenterol; 1978; 15(3):117-22. PubMed ID: 749847
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Lipoprotein X (LP-X) in the differential diagnosis of cholestasis in children, with special reference to biliary atresia].
    Duchnowska A; Wach K; Poradowska W
    Probl Med Wieku Rozwoj; 1979; 8():84-91. PubMed ID: 263531
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of lipoprotein-X in the pathogenesis of cholestatic hypercholesterolemia. Uptake of lipoprotein-X and its effect on 3-hydroxy-3-methylglutaryl coenzyme A reductase and chylomicron remnant removal in human fibroblasts, lymphocytes, and in the rat.
    Walli AK; Seidel D
    J Clin Invest; 1984 Sep; 74(3):867-79. PubMed ID: 6470142
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The value of clinical assessment in the diagnosis of icterus and cholestasis.
    Pasanen PA; Pikkarainen P; Alhava E; Partanen K; Pirinen A; Janatuinen E
    Ital J Gastroenterol; 1992; 24(6):313-9. PubMed ID: 1515656
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Lipoprotein-X. Methods of analysis and diagnostic significance in cholestasis].
    Raabo E; Franck C; Frey M; Ingwersen S
    Ugeskr Laeger; 1980 Jul; 142(31):1986-9. PubMed ID: 7404816
    [No Abstract]   [Full Text] [Related]  

  • 19. Liver biopsy in neonatal cholestasis: a review on statistical grounds.
    Zerbini MC; Gallucci SD; Maezono R; Ueno CM; Porta G; Maksoud JG; Gayotto LC
    Mod Pathol; 1997 Aug; 10(8):793-9. PubMed ID: 9267821
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Importance of liver puncture biopsy and endoscopic retrograde cholangiography in patients with chronic anicteric unexplained cholestasis. A retrospective study in 79 patients].
    Sapey T; Turlin B; Canva-Delcambre V; Mendler MH; Deugnier Y; Brissot P; Guyader D
    Gastroenterol Clin Biol; 1999 Feb; 23(2):178-85. PubMed ID: 10353011
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.